Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Access the form: Once your form is submitted, choose a payment plan, either a monthly brand-name option or a three-month prepaid plan for compounded medications
However, it's worth noting that rare cases of persistent gastrointestinal dysmotility have been reported in postmarketing surveillance, reinforcing why semaglutide is not recommended for patients with severe gastroparesis
It is not yet FDA approved for any indication
(Wegovy, Zepbound, or Foundayo only) Pregnancy and breastfeeding - speak with your provider if you are or plan to be pregnant or breastfeeding, as these GLP-1 agonists should only be used during pregnancy or breastfeeding if the potential benefit outweighs potential risk to the fetus or breastfed infant
